Viraleze registered for sale in Covid-ravaged India

「VIRALEZE」抗ウイルス点鼻スプレー、インドでの販売が公認 2021/6/11 (VIRALEZEの抗ウイルス成分である) SPL7013は,既に45カ国以上で承認されている製品に含まれており,英国,欧州,日本,東南アジア,南アフリカ,オーストラリア,ニュージーランドで販売されています。

Viraleze registered for sale in Covid-ravaged India Photo

VIRALEZE™ is an antiviral nasal spray that contains astodrimer sodium (SPL7013), which has been shown in laboratory studies to inactivate a broad spectrum of respiratory viruses, including >99.9% of coronavirus SARS-CoV-2, the virus that causes COVID-19.^

^Paull, J.R.A. et al. Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro (2021). Antiviral Research: https://doi.org/10.1016/j.antiviral.2021.105089.

VIRALEZE™ contains astodrimer sodium, which has been shown in laboratory studies to inactivate viruses, including SARS-CoV-2†, influenza and respiratory syncytial virus (RSV).

^Hou et al., 2020, Cell 182, 429–446, https://doi.org/10.1016/j.cell.2020.05.042 †Paull, J.R.A. et al. Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro (2021). Antiviral Research: https://doi.org/10.1016/j.antiviral.2021.105089.

Astodrimer sodium (also known as SPL7013) is a patented, precisely designed large molecule that cannot pass into the bloodstream and that acts locally at site of application in the nasal cavity.

Astodrimer sodium is included in products approved in >40 countries and available for sale in the UK, Europe, Japan, South East Asia, Australia and New Zealand.

Top Tweets About The Story

Top India Stories